Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL)
Clinical trial NCT02192021 · COMPLETED
Trial details
- NCT number
- NCT02192021
- Sponsor
- Falo, Louis, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-09
- Primary completion
- 2020-11-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.